These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

906 related articles for article (PubMed ID: 28768872)

  • 1. High-Risk Alphapapillomavirus Oncogenes Impair the Homologous Recombination Pathway.
    Wallace NA; Khanal S; Robinson KL; Wendel SO; Messer JJ; Galloway DA
    J Virol; 2017 Oct; 91(20):. PubMed ID: 28768872
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inactivation of the human papillomavirus E6 or E7 gene in cervical carcinoma cells by using a bacterial CRISPR/Cas RNA-guided endonuclease.
    Kennedy EM; Kornepati AV; Goldstein M; Bogerd HP; Poling BC; Whisnant AW; Kastan MB; Cullen BR
    J Virol; 2014 Oct; 88(20):11965-72. PubMed ID: 25100830
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-risk human papillomavirus oncogenes disrupt the Fanconi anemia DNA repair pathway by impairing localization and de-ubiquitination of FancD2.
    Khanal S; Galloway DA
    PLoS Pathog; 2019 Feb; 15(2):e1007442. PubMed ID: 30818369
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genomic Signatures in HPV-Associated Tumors.
    Hussain SS; Lundine D; Leeman JE; Higginson DS
    Viruses; 2021 Oct; 13(10):. PubMed ID: 34696429
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Beta human papillomavirus 8 E6 allows colocalization of non-homologous end joining and homologous recombination repair factors.
    Hu C; Bugbee T; Dacus D; Palinski R; Wallace N
    PLoS Pathog; 2022 Feb; 18(2):e1010275. PubMed ID: 35148356
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TALEN-mediated targeting of HPV oncogenes ameliorates HPV-related cervical malignancy.
    Hu Z; Ding W; Zhu D; Yu L; Jiang X; Wang X; Zhang C; Wang L; Ji T; Liu D; He D; Xia X; Zhu T; Wei J; Wu P; Wang C; Xi L; Gao Q; Chen G; Liu R; Li K; Li S; Wang S; Zhou J; Ma D; Wang H
    J Clin Invest; 2015 Jan; 125(1):425-36. PubMed ID: 25500889
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human papillomavirus E7 oncoprotein targets RNF168 to hijack the host DNA damage response.
    Sitz J; Blanchet SA; Gameiro SF; Biquand E; Morgan TM; Galloy M; Dessapt J; Lavoie EG; Blondeau A; Smith BC; Mymryk JS; Moody CA; Fradet-Turcotte A
    Proc Natl Acad Sci U S A; 2019 Sep; 116(39):19552-19562. PubMed ID: 31501315
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The synergistic therapeutic effect of cisplatin with Human papillomavirus E6/E7 short interfering RNA on cervical cancer cell lines in vitro and in vivo.
    Jung HS; Erkin OC; Kwon MJ; Kim SH; Jung JI; Oh YK; Her SW; Ju W; Choi YL; Song SY; Kim JK; Kim YD; Shim GY; Shin YK
    Int J Cancer; 2012 Apr; 130(8):1925-36. PubMed ID: 21630254
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HPV oncogenes expressed from only one of multiple integrated HPV DNA copies drive clonal cell expansion in cervical cancer.
    Yu L; Majerciak V; Lobanov A; Mirza S; Band V; Liu H; Cam M; Hughes SH; Lowy DR; Zheng Z-M
    mBio; 2024 May; 15(5):e0072924. PubMed ID: 38624210
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of human papillomavirus E6/E7 oncogene expression as cervical disease biomarker.
    Fontecha N; Basaras M; Hernáez S; Andía D; Cisterna R
    BMC Cancer; 2016 Nov; 16(1):852. PubMed ID: 27816058
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Homologous Recombination Repair Factors Rad51 and BRCA1 Are Necessary for Productive Replication of Human Papillomavirus 31.
    Chappell WH; Gautam D; Ok ST; Johnson BA; Anacker DC; Moody CA
    J Virol; 2015 Dec; 90(5):2639-52. PubMed ID: 26699641
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recombinant adenoviruses expressing HPV16/18 E7 upregulate the HDAC6 and DNMT3B genes in C33A cells.
    Shao Y; Shah PT; Su Q; Li S; Huang F; Wang J; Wang P; Wu C
    Front Cell Infect Microbiol; 2024; 14():1459572. PubMed ID: 39411320
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human papillomavirus type 16 E6 and E7 oncoproteins interact with the nuclear p53-binding protein 1 in an in vitro reconstructed 3D epithelium: new insights for the virus-induced DNA damage response.
    Squarzanti DF; Sorrentino R; Landini MM; Chiesa A; Pinato S; Rocchio F; Mattii M; Penengo L; Azzimonti B
    Virol J; 2018 Nov; 15(1):176. PubMed ID: 30445982
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Variations of human papillomavirus type 58 E6, E7, L1 genes and long control region in strains from women with cervical lesions in Liaoning province, China.
    Liu JH; Lu ZT; Wang GL; Zhou WQ; Liu C; Yang LX; Sun ZR; Ruan Q
    Infect Genet Evol; 2012 Oct; 12(7):1466-72. PubMed ID: 22659102
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DNA aneuploidy and integration of human papillomavirus type 16 e6/e7 oncogenes in intraepithelial neoplasia and invasive squamous cell carcinoma of the cervix uteri.
    Melsheimer P; Vinokurova S; Wentzensen N; Bastert G; von Knebel Doeberitz M
    Clin Cancer Res; 2004 May; 10(9):3059-63. PubMed ID: 15131043
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HPV16 oncogenes E6 or/and E7 may influence the methylation status of RASSFIA gene promoter region in cervical cancer cell line HT-3.
    Yin F; Wang N; Wang S; Yu F; Sun X; Yu X; Luo B; Zhao C; Wang Y
    Oncol Rep; 2017 Apr; 37(4):2324-2334. PubMed ID: 28260046
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitation of human papillomavirus 16 E6 and E7 DNA and RNA in residual material from ThinPrep Papanicolaou tests using real-time polymerase chain reaction analysis.
    Wang-Johanning F; Lu DW; Wang Y; Johnson MR; Johanning GL
    Cancer; 2002 Apr; 94(8):2199-210. PubMed ID: 12001118
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of cervical cancer cell growth in vitro and in vivo by lentiviral-vector mediated shRNA targeting the common promoter of HPV16 E6 and E7 oncogenes.
    Zhou J; Li B; Peng C; Wang F; Fu Z; Zhou C; Hong D; Ye F; Lü W; Xie X
    Antiviral Res; 2013 May; 98(2):305-13. PubMed ID: 23523766
    [TBL] [Abstract][Full Text] [Related]  

  • 19. RPRD1B is a potentially molecular target for diagnosis and prevention of human papillomavirus E6/E7 infection-induced cervical cancer: A case-control study.
    Wen N; Bian L; Gon J; Meng Y
    Asia Pac J Clin Oncol; 2021 Jun; 17(3):230-237. PubMed ID: 32866332
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systemic delivery of siRNA by actively targeted polyion complex micelles for silencing the E6 and E7 human papillomavirus oncogenes.
    Nishida H; Matsumoto Y; Kawana K; Christie RJ; Naito M; Kim BS; Toh K; Min HS; Yi Y; Matsumoto Y; Kim HJ; Miyata K; Taguchi A; Tomio K; Yamashita A; Inoue T; Nakamura H; Fujimoto A; Sato M; Yoshida M; Adachi K; Arimoto T; Wada-Hiraike O; Oda K; Nagamatsu T; Nishiyama N; Kataoka K; Osuga Y; Fujii T
    J Control Release; 2016 Jun; 231():29-37. PubMed ID: 26979870
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 46.